Dicerna Pharmaceuticals Garners $8,400,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cc4b138-0131-42dd-a220-b548acdfd631&Preview=1 -
Date
7/15/2008 -
Company Name
Dicerna Pharmaceuticals -
Mailing Address
15 Peterson Circle Sudbury, MA 01776 -
Company Description
Dicerna Pharmaceuticals is a venture-backed startup developing novel therapeutics in multiple therapeutic areas based on Dicer substrate technology, which makes use of the RNA interference mechanism. -
Website
http://www.dicerna.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,400,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Abingworth Management Inc -
Venture Investor
Oxford Bioscience Partners -
Venture Investor
Skyline Ventures
